GlassScriptPhysician profile
Karri A Buresh
NPI 1124009824
$8,626.64
in general payments reported to CMS, 2019-2025
25 companies · $1,675 in 2025
The $1,675 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,351 · 2020: $1,539 · 2021: $775 · 2022: $982 · 2023: $1,149 · 2024: $1,155 · 2025: $1,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,522 · Gift: $400 · Entertainment: $56.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,522.19 |
| Gift | $400.00 |
| Entertainment | $56.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,582.92 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Maculogix, INC. | $1,383.89 | 2019-2020 | |
| Alcon Vision LLC | $946.45 | 2021-2025 | Precision7, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $847.50 | 2022-2025 | Infuse, Biotrue One Day, Btod |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $553.69 | 2019-2021 | |
| Allergan, INC. | $444.32 | 2019 | |
| Visionary Optics LLC | $400.00 | 2025 | |
| Apellis Pharmaceuticals, INC. | $294.03 | 2025 | Syfovre |
| Oyster Point Pharma, INC. | $251.38 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $251.13 | 2020-2023 | Cequa |
| Glaukos Corporation | $238.85 | 2023-2024 | Ce-Marked Kxla System |
| Optos, INC. | $224.26 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $162.71 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $159.76 | 2020-2025 | Lipiflow System Activator (Disposable) |
| Abbvie INC. | $145.47 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $135.17 | 2022-2025 | Acuvue |
| Shire North American Group INC | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $114.44 | 2020-2023 | |
| Lkc Technologies, INC. | $91.94 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $83.27 | 2023 | Forum |
| Sight Sciences, INC. | $72.89 | 2023 | Tearcare System |
| Biotissue Holdings INC. | $46.22 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $32.83 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $19.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karri Buresh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.